CROs/Service Providers

Covance, Novartis collaborate to develop a clinical data warehouse

Wednesday, October 15, 2014 01:21 PM

Covance has entered an in-kind collaboration with Novartis Institutes for Biomedical Research (NIBR) to accelerate the development of a state-of-the-art clinical data warehouse designed to support data integration and meta-analysis for preclinical and clinical research.

More... »


Report: CROs an innovation partner in clinical trials

Thursday, October 9, 2014 11:33 AM

“Clinical trials today are more responsive, individualized and effective because it’s written into the DNA of CROs to challenge the status quo,’’ according to a new Association of Clinical Research Organizations (ACRO) report, Clinical Research: A Legacy of Innovation, A Future of Transformed Medicine.

More... »

Subscribe to The CenterWatch Monthly

DPx to expand facility in North Carolina, add 488 jobs

Thursday, October 9, 2014 08:00 AM

DPx, the “umbrella name” for Patheon’s three business units specializing in pharmaceutical services, fine chemicals and proprietary products and technologies, will expand operations in Pitt County, N.C. The company plans to create 488 jobs in Greenville, N.C. by the end of 2019 and invest $159 million to increase the site’s capabilities, as well as modernize the site and develop energy efficiency programs at the facility.

More... »

Survey: CROs exchange regulated clinical trial docs via outdated methods

Wednesday, October 8, 2014 01:38 PM

The vast majority of CROs surveyed lag behind sponsors in how they exchange trial master file (TMF) documents, according to a Veeva Systems survey, Veeva 2014 Paperless TMF Survey: The State of CRO TMFs.

More... »

INC Research files for initial public offering

Tuesday, October 7, 2014 12:27 PM

By Ronald Rosenberg
CenterWatch Staff Writer

INC Research Holdings, which has spent the past two decades acquiring 10 companies, has announced plans for an initial public offering expected to raise $150 million.

More... »

PPD acquires X-Chem

Tuesday, October 7, 2014 10:30 AM

Pharmaceutical Product Development (PPD), a Wilmington, N.C.-based CRO, has exercised its option to acquire the remaining minority ownership interest of X-Chem. X-Chem, a biotechnology company based in Waltham, Mass., will continue to operate as a biotechnology company with its entire existing staff, including its management team led by CEO and founder Richard W. Wagner, Ph.D., along with executive management team members Diala Ezzeddine, Ph.D., chief business officer; Matthew Clark, Ph.D., sr. vice president of research; and Lee Babiss as chairman of the board.

More... »

Bracket names Jeff Kinell CEO

Monday, October 6, 2014 06:54 AM

Bracket, a clinical trial specialty services provider, has announced the addition of Jeffrey W. Kinell as CEO and new member of its board of directors.

More... »

Parexel International acquires ClinIntel

Friday, October 3, 2014 10:58 AM

Global CRO Parexel International, headquartered in Waltham, Mass., has acquired privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in Crawley, U.K.

More... »

NCI co-funding Pharmatech Just-In-Time expansion

Thursday, October 2, 2014 02:13 PM

The National Cancer Institute (NCI) is co-funding Denver, Colo.-based CRO Pharmatech’s development of AccessPPM and expansion of its Just-In-Time enrollment programs.

More... »

Horizon Discovery Group acquires Sage Labs for $48M

Wednesday, October 1, 2014 01:18 PM

Horizon Discovery Group, a Cambridge, U.K.-based international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, has agreed to acquire Sage Labs, a St. Louis, Mo.-based provider of advanced in vivo transgenic disease models for use in preclinical research, for up to $16 million in cash and up to $32 million through the issue of new ordinary shares.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs